Virginia Cancer Specialists Hosts Advances in Genetic Risk Assessment Dinner for Physician Partners

Virginia Cancer Specialists Practice Blog

June 05, 2017
Virginia Cancer Specialists » VCS Practice News » Genetics » VCS Practice News » Genetic Risk Assessment » Virginia Cancer Specialists Hosts Advances in Genetic Risk Assessment Dinner for Physician Partners

Virginia Cancer Specialists Hosts Advances in Genetic Risk Assessment: Identifying and Managing Hereditary Breast Cancer Dinner

Virginia Cancer Specialists (VCS) held an event recently presenting Advances in Genetic Risk Assessment: Identifying and Managing Hereditary Breast Cancer to its physician partners in the Northern Virginia Area.  Over 60 Physicians and Clinical Partners were in attendance.  Myriad a leading molecular diagnostic company was the sponsor of the event.  Patricia Rodriguez, MD, Shawn Lipinski, ScM, CGC – presented the latest treatments and findings on Breast Cancer Genetics and Hereditary Cancer Syndromes: Impact on Patient Management.  Neelima Denduluri, M.D. also presented updates on Clinical Trials.

Shawn Lipinski, ScM, CGC and Patricia Rodriguez, M.D. Speak.

 

Anne Favret, M.D. mingles with Attendees.

 

 

Neelima Denduluri, M.D. Speaks on Clinical Trial Updates.

 

Schedule An Appointment Here